AILERON THERAPEUTICS INC (ALRN)
US00887A2042 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -15.73M | -27.33M | -26.16M | -21.16M | -29.37M | |||
| Depreciation Amortization | 119.00K | 170.00K | 120.00K | 160.00K | 160.00K | |||
| Change In Working Capital | -5.38M | 420.00K | 240.00K | -1.28M | 850.00K | |||
| Other non cash items | 1.19M | 1.88M | 2.05M | 1.80M | 1.89M | |||
| OPERATING CASH FLOW | -19.81M | -24.87M | -23.75M | -20.48M | -26.47M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -160.00K | -10.00K | -150.00K | |||
| Other Investing Activity | 16.20M | 26.46M | -35.76M | 6.42M | -2.66M | |||
| INVESTING CASH FLOW | 16.20M | 26.46M | -35.92M | 6.41M | -2.81M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | 390.00K | N/A | |||
| Stock Issued/Repurchased | N/A | 0.00 | 55.66M | 15.41M | 23.96M | |||
| Other Financing Activity | 15.79M | N/A | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | 15.79M | 0.00 | 55.66M | 15.80M | 23.96M | |||
| Exchange Rate Effect | -63.00K | N/A | N/A | N/A | N/A | |||
| CHANGE IN CASH | 12.12M | 1.59M | -4.01M | 1.73M | -5.32M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -19.81M | -24.87M | -23.75M | -20.48M | -26.47M | |||
| Capital Expenditure | N/A | 0.00 | -160.00K | -10.00K | -150.00K | |||
| FREE CASH FLOW | -19.81M | -24.87M | -23.91M | -20.49M | -26.62M | |||
All data in USD